A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine

NCT05850364 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1442
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sinovac Biotech Co., Ltd